Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters

Introduction: Therapeutic drug monitoring (TDM) and pharmacokinetic assessments of vancomycin would be essential to avoid vancomycin-associated nephrotoxicity and obtain optimal therapeutic and clinical responses. Different pharmacokinetic parameters, including trough concentration and area under th...

Full description

Bibliographic Details
Main Authors:	Parisa Ghasemiyeh, Afsaneh Vazin, Farid Zand, Elham Haem, Iman Karimzadeh, Amir Azadi, Mansoor Masjedi, Golnar Sabetian, Reza Nikandish, Soliman Mohammadi-Samani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Pharmacology
Subjects:	vancomycin therapeutic drug monitoring (TDM) pharmacokinetic parameters critically ill patients nephrotoxicity cut-off point
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.912202/full

Similar Items

The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns
by: Uranous Niroumand, et al.
Published: (2023-06-01)

Micronutrients Supplementation in Pregnant Women during COVID-19 Pandemy: Pros and Cons
by: Parisa Ghasemiyeh, et al.
Published: (2021-09-01)

Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
by: Wagner P, et al.
Published: (2022-10-01)

Laboratory correlation between vancomycin levels and serum creatinine in the nephrotoxicity of vancomycin
by: Luiza K.R.P. Araújo, et al.
Published: (2016-12-01)

Polymers Blending as Release Modulating Tool in Drug Delivery
by: Parisa Ghasemiyeh, et al.
Published: (2021-11-01)

The Effect of Vitamin C in Preventing Vancomycin-Induced Nephrotoxicity; A Randomized Clinical Trial Study
by: Mohamadreza Yazdani, et al.
Published: (2019-12-01)

Vitamin E in the prevention of vancomycin-induced nephrotoxicity
by: Rasool Soltani, et al.
Published: (2020-01-01)

In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
by: Nicole Papp, et al.
Published: (2022-05-01)

A SILAC-Based Approach Elicits the Proteomic Responses to Vancomycin-Associated Nephrotoxicity in Human Proximal Tubule Epithelial HK-2 Cells
by: Zhi-Ling Li, et al.
Published: (2016-01-01)

Iron Chelating Agents: Promising Supportive Therapies in Severe Cases of COVID-19?
by: Parisa Ghasemiyeh, et al.
Published: (2020-06-01)

Hydrogels as Drug Delivery Systems; Pros and Cons
by: Parisa Ghasemiyeh, et al.
Published: (2019-03-01)

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
by: Parisa Ghasemiyeh, et al.
Published: (2018-01-01)

Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
by: Medha D. Joshi, et al.
Published: (2023-05-01)

Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages
by: Simon Lagies, et al.
Published: (2021-09-01)

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
by: Kazutaka Oda, et al.
Published: (2021-09-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

The Serum Concentration of Vancomycin as a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Critically Ill Patients
by: Welder Zamoner, et al.
Published: (2022-01-01)

Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: Characterization and evaluation
by: Junli Liu, et al.
Published: (2015-06-01)

Serum Concentration of Vancomycin Is a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Septic Patients in Clinical and Surgical Wards
by: Zamoner W, et al.
Published: (2020-02-01)

Cyproterone acetate-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): preparation and optimization
by: Parisa Ghasemiyeh, et al.
Published: (2017-11-01)

Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China
by: Mo-Han Dong, et al.
Published: (2015-08-01)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)

Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Infections
by: Thanawat Chattaweelarp, et al.
Published: (2020-10-01)

Extremely high levels of vancomycin can cause severe renal toxicity
by: Barceló-Vidal J, et al.
Published: (2018-07-01)

Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
by: Claudia Sette, et al.
Published: (2023-10-01)

A machine learning model that emulates experts’ decision making in vancomycin initial dose planning
by: Tetsuo Matsuzaki, et al.
Published: (2022-04-01)

Vancomycin-induced nephrotoxicity with unusual high serum trough level in a critically ill young patient
by: Yi Xin Cheng, et al.
Published: (2016-01-01)

Vancomycin Revisited - 60 years later
by: Ethan eRubinstein, et al.
Published: (2014-10-01)

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
by: Ghasemiyeh P, et al.
Published: (2020-06-01)

Pharmacological agents for the prevention of colistin-induced nephrotoxicity
by: Mahtabalsadat Mirjalili, et al.
Published: (2022-05-01)

Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury
by: Linda Awdishu, et al.
Published: (2021-03-01)

Clinical pharmacokinetics of vancomycin in the neonate: a review
by: Gian Maria Pacifici, et al.
Published: (2012-07-01)

A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
by: Leonore Greybe, et al.
Published: (2023-11-01)

STUDY OF PREVENTIVE EFFECT OF MELATONIN ON HIGH DOSE VANCOMYCIN INDUCED NEPHROTOXICITY IN RABBITS
by: Shabana Ali, et al.
Published: (2018-12-01)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
by: Moeko Tsutsuura, et al.
Published: (2021-02-01)

Different therapeutic approaches in melasma: advances and limitations
by: Parisa Ghasemiyeh, et al.
Published: (2024-04-01)

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021-12-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)

The impact of Vancomycin loading dose on the emergency department in Saudi Arabia: a multicenter cohort study
by: Waad H. Al-Kathiri, et al.
Published: (2021-12-01)

Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
by: Erin Chung, et al.
Published: (2021-04-01)